All Sauce from Weekly Sauce:

The first known person with COVID-19 was a vendor in a large seafood market in Wuhan, China, claims an American scientist whose findings challenge the World Health Organization’s conclusion that the first patient was an accountant who lived miles from the market. Michael Worobey, a University of Arizona expert in tracing the evolution of viruses,…  read on >  read on >

There was no smallpox virus in frozen vials recently discovered at a vaccine research facility in Pennsylvania, the U.S. Centers for Disease Control and Prevention said Thursday. Instead of the variola virus that causes smallpox, lab tests showed that the vials contained vaccinia, the virus used in smallpox vaccine, according to the agency. On Nov.…  read on >  read on >

THURSDAY, Nov. 19, 2021 (HealthDay News) – People who live with chronic migraines suffer intense throbbing and pulsing, sensitivity to light and sound, nausea and vomiting. Could a plant-based diet, credited with a variety of positive health impacts, also help ease these chronic symptoms? It might. Researchers in New York have published a case study…  read on >  read on >

A COVID-19 vaccine booster shot gives cancer patients — especially those with blood cancer — much-needed protection, new research reports. “Our study demonstrates in clear terms how the booster shot can make all the difference for some people with compromised immune systems, such as people with cancer,” study co-author Dr. Balazs Halmos said in a…  read on >  read on >

Guidelines for treating movement problems in people in the early stages of Parkinson’s disease have been updated. The new treatment recommendations from the American Academy of Neurology (AAN) focus on dopaminergic medications, which increase dopamine levels or mimic dopamine effects. Parkinson’s is a movement disorder that occurs when nerve cells in the brain fail to…  read on >  read on >

Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines. “Aducanumab is not a cure for Alzheimer’s disease, yet since it has been approved by the [U.S. Food and Drug…  read on >  read on >